People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Chris Cavallo & Daughter Cristina Cavallo Co Founder's of The Robin Foundation Walk for Lives The Robin Foundation The Robin ...
Kenox Pharmaceuticals Inc (Kenox), a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), is proud to announce the addition of small scale ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
News Nation on MSN16h
FDA approves antidepressant nasal spray | Morning in AmericaThe FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT ...
WGAL Lancaster-Harrisburg on MSN18h
Lawmaker wants to require Pennsylvania high schools to have NarcanSchool nurses, teachers or other people trained and qualified would be authorized to administer the nasal spray to a student or staff member experiencing symptoms of an opioid overdose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback